Phosphorylation of Serine 1106 in the Catalytic Domain of Topoisomerase IIα Regulates Enzymatic Activity and Drug Sensitivity
Open Access
- 1 April 2003
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (15) , 12696-12702
- https://doi.org/10.1074/jbc.m300837200
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cellular roles of DNA topoisomerases: a molecular perspectiveNature Reviews Molecular Cell Biology, 2002
- Culprit and victim – DNA topoisomerase IIThe Lancet Oncology, 2002
- Tumor Cell Death Induced by Topoisomerase-Targeting DrugsAnnual Review of Pharmacology and Toxicology, 2001
- Attenuation of drug-stimulated topoisomerase II–DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIαBiochemical Journal, 1998
- Cell Cycle Phase-specific Phosphorylation of Human Topoisomerase IIαJournal of Biological Chemistry, 1995
- Topoisomerase Poisons: Harnessing the Dark Side of Enzyme MechanismJournal of Biological Chemistry, 1995
- Human Topoisomerase IIalpha is Phosphorylated in a Cell-Cycle Phase-Dependent Manner by a Proline-Directed KinaseEuropean Journal of Biochemistry, 1995
- Structure and function of type II DNA topoisomerasesBiochemical Journal, 1994
- In vivo phosphorylation of the 170-kDa form of eukaryotic DNA topoisomerase IIPublished by Elsevier ,1989
- Phosphorylation of DNA topoisomerase II by casein kinase II: modulation of eukaryotic topoisomerase II activity in vitro.Proceedings of the National Academy of Sciences, 1985